Itron (NASDAQ:ITRI) SVP Justin Patrick Sells 206 Shares of Stock

Itron, Inc. (NASDAQ:ITRI) SVP Justin Patrick sold 206 shares of the firm’s stock in a transaction dated Wednesday, May 20th. The shares were sold at an average price of $79.60, for a total value of $16,397.60. Following the sale, the senior vice president owned 32,925 shares of the company’s stock, valued at $2,620,830. This represents a 0.62% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Itron Stock Up 0.6%

Shares of Itron stock opened at $81.85 on Friday. The business has a 50-day moving average of $88.63 and a 200-day moving average of $94.60. The company has a debt-to-equity ratio of 0.97, a current ratio of 2.66 and a quick ratio of 2.24. The company has a market capitalization of $3.63 billion, a PE ratio of 13.05, a P/E/G ratio of 0.71 and a beta of 1.35. Itron, Inc. has a 1-year low of $77.77 and a 1-year high of $142.00.

Itron (NASDAQ:ITRI) last announced its earnings results on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.23. The company had revenue of $586.98 million during the quarter, compared to the consensus estimate of $572.04 million. Itron had a return on equity of 19.54% and a net margin of 12.31%.The company’s revenue was down 3.3% on a year-over-year basis. During the same period last year, the firm earned $1.52 earnings per share. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. As a group, equities analysts forecast that Itron, Inc. will post 6.01 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the company. Oppenheimer raised their target price on Itron from $133.00 to $135.00 and gave the company an “outperform” rating in a research note on Thursday, April 16th. TD Cowen lowered their target price on Itron from $145.00 to $130.00 and set a “buy” rating for the company in a research note on Wednesday, April 29th. Roth Mkm reaffirmed a “buy” rating and set a $136.00 price target on shares of Itron in a research report on Wednesday, April 29th. Stephens reaffirmed an “overweight” rating and set a $130.00 price target on shares of Itron in a research report on Wednesday. Finally, Needham & Company LLC initiated coverage on shares of Itron in a research report on Friday, March 6th. They set a “buy” rating and a $124.00 price target on the stock. Eight equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $131.22.

Key Itron News

Here are the key news stories impacting Itron this week:

• Positive Sentiment: Stephens reaffirmed its Overweight rating on Itron and kept a $130 price target, implying substantial upside from the current share price. Stephens reaffirms Overweight on Itron
• Neutral Sentiment: Several Itron executives sold small blocks of shares, but the filings say the transactions were mainly to cover tax withholding from equity award vesting, which makes the insider activity less concerning than open-market selling. SEC filing for insider sale
• Negative Sentiment: Zacks Research cut multiple earnings estimates for Itron, including a sharp reduction for Q4 2027 and a lower FY2027 forecast, signaling softer profit expectations ahead. Zacks Research estimate cuts for Itron

Hedge Funds Weigh In On Itron

Large investors have recently bought and sold shares of the business. Employees Retirement System of Texas bought a new position in Itron in the third quarter worth about $32,000. Private Trust Co. NA lifted its holdings in Itron by 112.4% in the fourth quarter. Private Trust Co. NA now owns 274 shares of the scientific and technical instruments company’s stock worth $25,000 after acquiring an additional 145 shares during the last quarter. Optiver Holding B.V. bought a new position in Itron in the third quarter worth about $36,000. Northwestern Mutual Wealth Management Co. lifted its holdings in Itron by 343.6% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 346 shares of the scientific and technical instruments company’s stock worth $46,000 after acquiring an additional 268 shares during the last quarter. Finally, Aster Capital Management DIFC Ltd bought a new position in Itron in the third quarter worth about $44,000. Institutional investors own 96.19% of the company’s stock.

About Itron

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.